Shandong Xinhua Pharmaceutical Company Limited
Symbol: 000756.SZ
SHZ
16.15
CNYDzisiejsza cena rynkowa
22.4147
Wskaźnik P/E
2.9139
Wskaźnik PEG
8.86B
Kapitalizacja MRK
- 0.01%
Rentowność DIV
Shandong Xinhua Pharmaceutical Company Limited (000756-SZ) Sprawozdania finansowe
Bilans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 3643.84 | 918.3 | 1158.7 | 744.7 | ||||||||||||||||||||||||||||||
balance-sheet.row.short-term-investments | -137.64 | 0 | -48.4 | -56.3 | ||||||||||||||||||||||||||||||
balance-sheet.row.net-receivables | 4745.26 | 1017.1 | 1035.4 | 937.2 | ||||||||||||||||||||||||||||||
balance-sheet.row.inventory | 4427.67 | 1313 | 1212 | 1027.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-current-assets | 237.57 | 65.9 | 50.8 | 44.6 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-current-assets | 13054.34 | 3314.3 | 3457 | 2754 | ||||||||||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 16128.64 | 4082.6 | 4000.5 | 3765.7 | ||||||||||||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
balance-sheet.row.intangible-assets | 1913.47 | 494.9 | 474.1 | 466.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 1913.47 | 494.9 | 474.1 | 466.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.long-term-investments | 1176.32 | 275.3 | 287.5 | 316.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.tax-assets | 153.72 | 91.6 | 16 | 15.2 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 393.23 | 95.6 | 30.1 | 14.2 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 19765.37 | 5040 | 4808.2 | 4578.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-assets | 32819.72 | 8354.3 | 8265.1 | 7332 | ||||||||||||||||||||||||||||||
balance-sheet.row.account-payables | 3935.84 | 666.4 | 1090.1 | 1066.4 | ||||||||||||||||||||||||||||||
balance-sheet.row.short-term-debt | 2671.86 | 1073.2 | 835.5 | 693.3 | ||||||||||||||||||||||||||||||
balance-sheet.row.tax-payables | 102.71 | 5 | 33.7 | 28.2 | ||||||||||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 3207.47 | 799.4 | 548.4 | 350.5 | ||||||||||||||||||||||||||||||
Deferred Revenue Non Current | 411.66 | 100.7 | 118.4 | 132.2 | ||||||||||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 490.44 | - | - | - | ||||||||||||||||||||||||||||||
balance-sheet.row.other-current-liab | 636.64 | 597.3 | 639.7 | 45.6 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 4086.23 | 971.9 | 756.7 | 1179 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 7.07 | 1.6 | 2.7 | 4.3 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-liab | 13681.05 | 3457.9 | 3915.2 | 3680.9 | ||||||||||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
balance-sheet.row.common-stock | 2706.46 | 674.7 | 669.6 | 627.4 | ||||||||||||||||||||||||||||||
balance-sheet.row.retained-earnings | 9120.77 | 2305.4 | 1988.1 | 1709.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 4793.33 | 819.2 | 744.7 | 647.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 1507.66 | 753.8 | 724.1 | 484.4 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 18128.21 | 4553.1 | 4126.5 | 3467.9 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 32819.72 | 8354.3 | 8265.1 | 7332 | ||||||||||||||||||||||||||||||
balance-sheet.row.minority-interest | 889.79 | 222.6 | 223.4 | 183.2 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-equity | 19018 | 4775.8 | 4349.9 | 3651.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 32819.72 | - | - | - | ||||||||||||||||||||||||||||||
Total Investments | 1038.68 | 275.3 | 239.2 | 260.2 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-debt | 5880.91 | 1874.2 | 1383.9 | 1043.8 | ||||||||||||||||||||||||||||||
balance-sheet.row.net-debt | 2237.07 | 955.8 | 225.1 | 299.1 |
Rachunek przepływów pieniężnych
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 486.79 | 496.5 | 426.3 | 362.1 | ||||||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 5.33 | 520.3 | 484.8 | 434.3 | ||||||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 577.52 | 6 | 20 | 13.7 | ||||||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 80.43 | -1917.3 | 46.4 | 4 | ||||||||||||||||||||||||||
cash-flows.row.change-in-working-capital | -491.34 | -876.8 | -265.4 | -539.6 | ||||||||||||||||||||||||||
cash-flows.row.account-receivables | -423.54 | -423.5 | -717.3 | -751.1 | ||||||||||||||||||||||||||
cash-flows.row.inventory | -120.86 | -120.9 | -200.1 | 76.2 | ||||||||||||||||||||||||||
cash-flows.row.account-payables | 0 | -332.4 | 632.1 | 121.6 | ||||||||||||||||||||||||||
cash-flows.row.other-working-capital | 53.07 | 0 | 20 | 13.7 | ||||||||||||||||||||||||||
cash-flows.row.other-non-cash-items | -144.29 | 2044.7 | 46.1 | -15.4 | ||||||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 487.09 | 0 | 0 | 0 | ||||||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -321.28 | -325.1 | -244.8 | -249.2 | ||||||||||||||||||||||||||
cash-flows.row.acquisitions-net | 11.27 | 11.9 | 45.3 | 19.8 | ||||||||||||||||||||||||||
cash-flows.row.purchases-of-investments | -9.94 | 0 | -45.3 | -19.8 | ||||||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 3.07 | 8.2 | 7.9 | 9.1 | ||||||||||||||||||||||||||
cash-flows.row.other-investing-activites | 15.04 | -8.2 | 7.9 | 2.4 | ||||||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -301.84 | -313.3 | -228.9 | -237.7 | ||||||||||||||||||||||||||
cash-flows.row.debt-repayment | -572.67 | -25.7 | -888.7 | -559.7 | ||||||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
cash-flows.row.dividends-paid | -173.23 | -134.9 | -163 | -148.4 | ||||||||||||||||||||||||||
cash-flows.row.other-financing-activites | 758.03 | -35.5 | 921 | 568.4 | ||||||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -122.9 | -196.1 | -130.7 | -139.7 | ||||||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 12.4 | 6.9 | 15.7 | -7.9 | ||||||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 88.83 | -240.4 | 414.4 | -126.2 | ||||||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 3262.6 | 918.3 | 1010.8 | 596.4 | ||||||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 3173.78 | 1158.7 | 596.4 | 722.6 | ||||||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 487.09 | 273.4 | 758.2 | 259.1 | ||||||||||||||||||||||||||
cash-flows.row.capital-expenditure | -321.28 | -325.1 | -244.8 | -249.2 | ||||||||||||||||||||||||||
cash-flows.row.free-cash-flow | 165.81 | -51.7 | 513.5 | 9.9 |
Wiersz rachunku zysków i strat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 7922.31 | 8008.7 | 7503 | 6560.1 | ||||||||||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 5715.98 | 5800.2 | 5465.7 | 4786.4 | ||||||||||||||||||||||||||||||
income-statement-row.row.gross-profit | 2206.33 | 2208.5 | 2037.3 | 1773.7 | ||||||||||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
income-statement-row.row.research-development | 449.03 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 139.5 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 718.33 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.other-expenses | -26.24 | -63.4 | 333.4 | 244.4 | ||||||||||||||||||||||||||||||
income-statement-row.row.operating-expenses | 1663.48 | 1696 | 1493.9 | 1274.7 | ||||||||||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 7379.46 | 7496.3 | 6959.6 | 6061.1 | ||||||||||||||||||||||||||||||
income-statement-row.row.interest-income | 13.12 | 12.3 | 10.5 | 8.8 | ||||||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 38.56 | 41.1 | 49.7 | 53.1 | ||||||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 718.33 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -1.49 | 18.9 | -4.9 | -4.4 | ||||||||||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -26.24 | -63.4 | 333.4 | 244.4 | ||||||||||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | -1.49 | 18.9 | -4.9 | -4.4 | ||||||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 38.56 | 41.1 | 49.7 | 53.1 | ||||||||||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 197.93 | 520.3 | 572.6 | 511.6 | ||||||||||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 716.06 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.operating-income | 518.13 | 512.4 | 476.7 | 425.6 | ||||||||||||||||||||||||||||||
income-statement-row.row.income-before-tax | 516.64 | 531.3 | 471.8 | 421.2 | ||||||||||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 19.18 | 26.6 | 45.5 | 59.2 | ||||||||||||||||||||||||||||||
income-statement-row.row.net-income | 486.79 | 496.5 | 411.1 | 348.5 |
Często zadawane pytania
Ile wynosi Shandong Xinhua Pharmaceutical Company Limited (000756.SZ) aktywów ogółem?
Shandong Xinhua Pharmaceutical Company Limited (000756.SZ) całkowite aktywa to 8354338037.000.
Jaki jest roczny przychód przedsiębiorstwa?
Roczny przychód to 4064436167.000.
Jaka jest marża zysku firmy?
Marża zysku firmy to 0.278.
Czym są wolne przepływy pieniężne firmy?
Wolne przepływy pieniężne to 0.245.
Jaka jest marża zysku netto przedsiębiorstwa?
Marża zysku netto to 0.061.
Jaki jest całkowity przychód firmy?
Całkowity przychód to 0.065.
Co to jest Shandong Xinhua Pharmaceutical Company Limited (000756.SZ) zysk netto (dochód netto)?
Zysk netto (dochód netto) wynosi 496512201.000.
Jakie jest całkowite zadłużenie firmy?
Całkowite zadłużenie to 1874155569.000.
Ile wynoszą koszty operacyjne?
Wydatki operacyjne to 1696039196.000.
Jaka jest wartość gotówki firmy?
Środki pieniężne przedsiębiorstwa to 922054214.000.